OSAM
O'Shaughnessy Asset Management Portfolio holdings
AUM
$14.7B
1-Year Return
27.21%
This Quarter Return
+14.78%
1 Year Return
+27.21%
3 Year Return
+99.31%
5 Year Return
+208.2%
10 Year Return
+368.11%
AUM
$4.51B
AUM Growth
+$836M
(+23%)
Cap. Flow
+$357M
Cap. Flow
% of AUM
7.92%
Top 10 Holdings %
Top 10 Hldgs %
18.93%
Holding
2,549
New
327
Increased
1,009
Reduced
679
Closed
75
Top Buys
| 1 |
Royal Bank of Canada
RY
|
+$34.6M |
| 2 |
Philip Morris
PM
|
+$28.4M |
| 3 |
Bank of Montreal
BMO
|
+$26.7M |
| 4 |
Enbridge
ENB
|
+$23.5M |
| 5 |
Manulife Financial
MFC
|
+$22.7M |
Top Sells
| 1 |
Eli Lilly
LLY
|
+$36M |
| 2 |
MetLife
MET
|
+$32.1M |
| 3 |
Waters Corp
WAT
|
+$26.4M |
| 4 |
Howmet Aerospace
HWM
|
+$23.4M |
| 5 |
Ally Financial
ALLY
|
+$19.6M |
Sector Composition
| 1 | Financials | 24.12% |
| 2 | Technology | 13.59% |
| 3 | Industrials | 11.75% |
| 4 | Healthcare | 10.18% |
| 5 | Consumer Discretionary | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1226
WisdomTree US SmallCap Earnings Fund
EES
$635M
| $93K | ﹤0.01% |
1,970
| – | – |
|
1227
Phreesia
PHR
$1.45B
| $93K | ﹤0.01% |
1,789
| – | – |
|
1228
Revolution Medicines
RVMD
$8.7B
| $92K | ﹤0.01% |
2,010
| – | – |
|
1229
Codexis
CDXS
$219M
| $91K | ﹤0.01% |
3,985
+3,855
| +2,965% | +$88K |
|
1230
Daktronics
DAKT
$1.15B
| $91K | ﹤0.01% |
14,528
+6,730
| +86% | +$42.2K |
|
1231
FibroGen
FGEN
$48.6M
| $91K | ﹤0.01% |
105
| – | – |
|
1232
HDFC Bank
HDB
$179B
| $91K | ﹤0.01% |
1,168
+723
| +162% | +$56.3K |
|
1233
Mativ Holdings
MATV
$674M
| $91K | ﹤0.01% |
1,863
-1,377
| -43% | -$67.3K |
|
1234
PotlatchDeltic
PCH
$3.2B
| $91K | ﹤0.01% |
1,722
+1,413
| +457% | +$74.7K |
|
|
ONIT
1235
Onity Group Inc.
ONIT
$367M
| $91K | ﹤0.01% |
3,213
-2,557
| -44% | -$72.4K |
|
1236
Eversource Energy
ES
$24.4B
| $90K | ﹤0.01% |
1,037
-247
| -19% | -$21.4K |
|
1237
Kura Oncology
KURA
$711M
| $90K | ﹤0.01% |
3,178
| – | – |
|
1238
Richardson Electronics
RELL
$141M
| $90K | ﹤0.01% |
+14,165
| New | +$90K |
|
|
SRNE
1239
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $90K | ﹤0.01% |
10,901
+9,737
| +837% | +$80.4K |
|
1240
American Woodmark
AMWD
$995M
| $89K | ﹤0.01% |
907
-1
| -0.1% | -$98 |
|
1241
Biglari Holdings Class B
BH
$943M
| $89K | ﹤0.01% |
667
-996
| -60% | -$133K |
|
1242
Lindsay Corp
LNN
$1.52B
| $89K | ﹤0.01% |
+532
| New | +$89K |
|
1243
Public Service Enterprise Group
PEG
$41.3B
| $89K | ﹤0.01% |
1,471
-282
| -16% | -$17.1K |
|
1244
Sanmina
SANM
$6.24B
| $89K | ﹤0.01% |
2,143
-479
| -18% | -$19.9K |
|
1245
Vir Biotechnology
VIR
$695M
| $89K | ﹤0.01% |
+1,729
| New | +$89K |
|
1246
Viatris
VTRS
$11.6B
| $89K | ﹤0.01% |
6,374
-30,932
| -83% | -$432K |
|
1247
Alico
ALCO
$260M
| $88K | ﹤0.01% |
2,932
-7,318
| -71% | -$220K |
|
1248
BioCryst Pharmaceuticals
BCRX
$1.66B
| $88K | ﹤0.01% |
+8,663
| New | +$88K |
|
1249
RingCentral
RNG
$2.75B
| $88K | ﹤0.01% |
295
+30
| +11% | +$8.95K |
|
|
FLG
1250
Flagstar Financial, Inc.
FLG
$5.27B
| $88K | ﹤0.01% |
2,322
-1,214
| -34% | -$46K |
|